Reviewed,
UniProtKB/Swiss-Prot P48634 (BAT2_HUMAN)
Last modified
July 7, 2009.
Version 79.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Large proline-rich protein BAT2 Alternative name(s): HLA-B-associated transcript 2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 2157 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May play a role in the regulation of pre-mRNA splicing. Ref.9 |
| Subcellular location | |
| Tissue specificity | Limited to cell-lines of leukemic origin. |
| Developmental stage | Broadly expressed during the 11th week of gestation, with highest levels in the central nervous system, spinal ganglia, osteoblasts and osteocytes (at protein level). Ref.12 |
| Sequence caution | The sequence AAA35585.1 differs from that shown. Reason: Frameshift at positions 38 and 58. The sequence AAA35586.1 differs from that shown. Reason: Frameshift at positions 38 and 58. The sequence CAA78744.1 differs from that shown. Reason: Frameshift at positions 38 and 58. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Repeat |
| PTM | Phosphoprotein |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Cellular component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-SubCell nucleusInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | protein binding Ref.9 Inferred from physical interaction. Source: IntAct |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ATXN1 | P54253 | 1 | EBI-347545,EBI-930964 | |
| C1QBP | Q07021 | 1 | EBI-347545,EBI-347528 | |
| CCR10 | P46092 | 1 | EBI-347545,EBI-348022 | |
| CPSF1 | Q10570 | 1 | EBI-347545,EBI-347859 | |
| DDX20 | Q9UHI6 | 1 | EBI-347545,EBI-347658 | |
| EIF3E | P60228 | 1 | EBI-347545,EBI-347740 | |
| FGA | P02671 | 1 | EBI-347545,EBI-348571 | |
| GANAB | Q14697 | 1 | EBI-347545,EBI-348004 | |
| GRB2 | P62993 | 1 | EBI-347545,EBI-401755 | |
| HNRNPA1 | P09651-2 | 1 | EBI-347545,EBI-352677 | |
| HNRNPM | P52272 | 1 | EBI-347545,EBI-486809 | |
| IFT88 | Q13099 | 1 | EBI-347545,EBI-347427 | |
| IMMT | Q16891 | 1 | EBI-347545,EBI-473801 | |
| MAD2L2 | Q9UI95 | 1 | EBI-347545,EBI-77889 | |
| MAN2C1 | Q9NTJ4 | 1 | EBI-347545,EBI-348635 | |
| P4HA2 | O15460 | 1 | EBI-347545,EBI-348033 | |
| PRMT2 | P55345 | 1 | EBI-347545,EBI-78458 | |
| PSMA3 | P25788 | 1 | EBI-347545,EBI-348380 | |
| QARS | P47897 | 1 | EBI-347545,EBI-347462 | |
| SSR3 | Q9UNL2 | 1 | EBI-347545,EBI-1043938 | |
| UBAP2L | Q14157 | 1 | EBI-347545,EBI-347762 |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | |||||||||
| Isoform 1 (identifier: P48634-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | |||||||||
| Isoform 2 (identifier: P48634-2) The sequence of this isoform differs from the canonical sequence as follows: 413-424: Missing. 1050-1148: RSREFRSYRE...PPPPGAPPSP → QANSAVTESF...PTTRSPTLHR 1155-1177: ARGGRVFTPRGVPSRRGRGGGRP → CPGVGESSLPEGAISPGPRRREA 1852-1864: AMDSQLHPNSGGF → SHGLSITSKQWRL | |||||||||
| Isoform 3 (identifier: P48634-3) The sequence of this isoform differs from the canonical sequence as follows: 1050-1148: RSREFRSYRE...PPPPGAPPSP → QANSAVTESF...PTTRSPTLHR 1155-1177: ARGGRVFTPRGVPSRRGRGGGRP → CPGVGESSLPEGAISPGPRRREA 1852-1864: AMDSQLHPNSGGF → SHGLSITSKQWRL | |||||||||
Sequence annotation (Features) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
| Sequence conflict | 1082 | 1 | M → L in CAA78744. Ref.7 | ||||||
| Isoform 4 (identifier: P48634-4) The sequence of this isoform differs from the canonical sequence as follows: 834-1457: Missing. | |||||||||
| Note: No experimental confirmation available. | |||||||||
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 2157 | 2157 | Large proline-rich protein BAT2 | PRO_0000064829 | |||||
Regions | |||||||||
| Repeat | 41 – 95 | 55 | 1-1 | ||||||
| Repeat | 98 – 154 | 57 | 1-2 | ||||||
| Repeat | 281 – 337 | 57 | 1-3 | ||||||
| Repeat | 337 – 430 | 94 | 2-1 | ||||||
| Repeat | 488 – 561 | 74 | 2-2 | ||||||
| Repeat | 1757 – 1812 | 56 | 1-4 | ||||||
| Repeat | 1916 – 1965 | 50 | 3-1 | ||||||
| Repeat | 1982 – 2031 | 50 | 3-2 | ||||||
| Repeat | 2057 – 2106 | 50 | 3-3 | ||||||
| Region | 41 – 1812 | 1772 | 4 X 57 AA type A repeats | ||||||
| Region | 337 – 561 | 225 | 2 X type B repeats | ||||||
| Region | 1916 – 2106 | 191 | 3 X 50 AA type C repeats | ||||||
| Compositional bias | 466 – 471 | 6 | Poly-Arg | ||||||
| Compositional bias | 472 – 475 | 4 | Poly-Glu | ||||||
| Compositional bias | 658 – 669 | 12 | Poly-Gln | ||||||
| Compositional bias | 696 – 700 | 5 | Poly-Pro | ||||||
| Compositional bias | 826 – 833 | 8 | Poly-Pro | ||||||
| Compositional bias | 913 – 916 | 4 | Poly-Pro | ||||||
| Compositional bias | 955 – 958 | 4 | Poly-Pro | ||||||
| Compositional bias | 1139 – 1142 | 4 | Poly-Pro | ||||||
| Compositional bias | 1239 – 1244 | 6 | Poly-Arg | ||||||
| Compositional bias | 1355 – 1360 | 6 | Poly-Gly | ||||||
| Compositional bias | 1413 – 1421 | 9 | Poly-Gly | ||||||
| Compositional bias | 1451 – 1457 | 7 | Poly-Pro | ||||||
Amino acid modifications | |||||||||
| Modified residue | 114 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 166 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 204 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 342 | 1 | Phosphoserine Ref.15 Ref.13 Ref.18 | ||||||
| Modified residue | 350 | 1 | Phosphoserine Ref.15 Ref.13 Ref.18 | ||||||
| Modified residue | 380 | 1 | Phosphoserine Ref.18 Ref.10 | ||||||
| Modified residue | 383 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 456 | 1 | Phosphoserine Ref.15 Ref.18 | ||||||
| Modified residue | 517 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 609 | 1 | Phosphothreonine Ref.17 | ||||||
| Modified residue | 610 | 1 | Phosphothreonine Ref.18 Ref.10 | ||||||
| Modified residue | 759 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 761 | 1 | Phosphoserine Ref.15 Ref.18 Ref.10 | ||||||
| Modified residue | 764 | 1 | Phosphoserine Ref.15 Ref.18 | ||||||
| Modified residue | 766 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 782 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 808 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 997 | 1 | Phosphothreonine Ref.18 | ||||||
| Modified residue | 1004 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 1014 | 1 | Phosphoserine Ref.18 Ref.11 | ||||||
| Modified residue | 1085 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 1087 | 1 | Phosphothreonine Ref.18 | ||||||
| Modified residue | 1089 | 1 | Phosphoserine Ref.13 Ref.18 | ||||||
| Modified residue | 1092 | 1 | Phosphoserine Ref.13 Ref.18 | ||||||
| Modified residue | 1094 | 1 | Phosphotyrosine Ref.18 | ||||||
| Modified residue | 1147 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 1219 | 1 | Phosphoserine Ref.13 Ref.18 Ref.10 Ref.17 Ref.16 | ||||||
| Modified residue | 1306 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 1347 | 1 | Phosphothreonine Ref.18 Ref.14 | ||||||
| Modified residue | 1353 | 1 | Phosphothreonine By similarity | ||||||
Natural variations | |||||||||
| Alternative sequence | 413 – 424 | 12 | Missing in isoform 2. | VSP_015099 | |||||
| Alternative sequence | 834 – 1457 | 624 | Missing in isoform 4. | VSP_030865 | |||||
| Alternative sequence | 1050 – 1148 | 99 | RSREF…APPSP → QANSAVTESFEEMMGVEVGQ GDQTTLLLPEAAMPARHGAR VQSMRKSPSGAGSGAQKQAA RPMRVIWLLQTRRLPHPRRE HSPRSSRSPTTRSPTLHR in isoform 2 and isoform 3. | VSP_015100 | |||||
| Alternative sequence | 1155 – 1177 | 23 | ARGGR…GGGRP → CPGVGESSLPEGAISPGPRR REA in isoform 2 and isoform 3. | VSP_015101 | |||||
| Alternative sequence | 1852 – 1864 | 13 | AMDSQ…NSGGF → SHGLSITSKQWRL in isoform 2 and isoform 3. | VSP_015102 | |||||
| Natural variant | 57 | 1 | P → R: dbSNP rs1062968. Ref.1 | VAR_023215 | |||||
| Natural variant | 82 | 1 | D → V: dbSNP rs6921213. | VAR_045992 | |||||
| Natural variant | 106 | 1 | P → L: dbSNP rs2280801. Ref.2 Ref.5 | VAR_023216 | |||||
| Natural variant | 477 | 1 | R → C: dbSNP rs17857493. Ref.6 | VAR_045993 | |||||
| Natural variant | 544 | 1 | K → T: dbSNP rs1046080. Ref.1 Ref.5 | VAR_023217 | |||||
| Natural variant | 694 | 1 | Q → K: dbSNP rs2844469. Ref.7 | VAR_023218 | |||||
| Natural variant | 742 | 1 | D → E: dbSNP rs1046081. Ref.1 | VAR_023219 | |||||
| Natural variant | 804 | 1 | R → C: dbSNP rs11538262. | VAR_045994 | |||||
| Natural variant | 1087 | 1 | T → I in a breast cancer sample; somatic mutation. Ref.20 | VAR_035796 | |||||
| Natural variant | 1152 | 1 | R → H in a breast cancer sample; somatic mutation. Ref.20 | VAR_035797 | |||||
| Natural variant | 1285 | 1 | G → A: dbSNP rs2736158. Ref.3 | VAR_023220 | |||||
| Natural variant | 1407 | 1 | S → N: dbSNP rs35464047. | VAR_045995 | |||||
| Natural variant | 1415 | 1 | G → A: dbSNP rs2857703. Ref.7 | VAR_023221 | |||||
| Natural variant | 1503 | 1 | P → L: dbSNP rs2272593. Ref.5 Ref.6 | VAR_023222 | |||||
| Natural variant | 1544 | 1 | G → D: dbSNP rs34175432. | VAR_045996 | |||||
| Natural variant | 1563 | 1 | R → Q: dbSNP rs11538263. | VAR_045997 | |||||
| Natural variant | 1740 | 1 | R → H: dbSNP rs1046089. Ref.5 Ref.3 | VAR_023223 | |||||
| Natural variant | 1744 | 1 | G → A: dbSNP rs2844491. Ref.7 | VAR_023224 | |||||
| Natural variant | 1774 | 1 | V → M: dbSNP rs11538264. | VAR_045998 | |||||
| Natural variant | 1775 | 1 | V → M: dbSNP rs11538264. | VAR_023225 | |||||
| Natural variant | 1895 | 1 | V → L: dbSNP rs3132453. Ref.5 | VAR_023226 | |||||
| Natural variant | 2006 | 1 | P → S: dbSNP rs10885. Ref.5 | VAR_023227 | |||||
| Natural variant | 2075 | 1 | R → W: dbSNP rs34137317. | VAR_056742 | |||||
| Natural variant | 2130 | 1 | P → L: dbSNP rs1046756. Ref.3 | VAR_023228 | |||||
Experimental info | |||||||||
| Sequence conflict | 57 | 1 | P → A in CAA78744. Ref.7 | ||||||
| Sequence conflict | 107 – 123 | 17 | ESQPL…SNQPK → NRTTAGFTDACLQPAE in CAA78744. Ref.7 | ||||||
| Sequence conflict | 762 | 1 | G → L in AAA35585. Ref.1 | ||||||
| Sequence conflict | 762 | 1 | G → L in AAA35586. Ref.1 | ||||||
| Sequence conflict | 762 | 1 | G → R in CAA78744. Ref.7 | ||||||
| Sequence conflict | 764 | 1 | S → L in AAA35585. Ref.1 | ||||||
| Sequence conflict | 764 | 1 | S → L in AAA35586. Ref.1 | ||||||
| Sequence conflict | 764 | 1 | S → L in CAA78744. Ref.7 | ||||||
| Sequence conflict | 846 | 1 | A → T in CAA78744. Ref.7 | ||||||
| Sequence conflict | 902 – 911 | 10 | PARGVGSGGQ → LPASRSGA in AAA35585. Ref.1 | ||||||
| Sequence conflict | 902 – 911 | 10 | PARGVGSGGQ → LPASRSGA in AAA35586. Ref.1 | ||||||
| Sequence conflict | 902 – 911 | 10 | PARGVGSGGQ → LPASRSGA in CAA78744. Ref.7 | ||||||
| Sequence conflict | 934 | 1 | R → G in AAH42295. Ref.6 | ||||||
| Sequence conflict | 1049 | 1 | A → G in AAA35585. Ref.1 | ||||||
| Sequence conflict | 1049 | 1 | A → G in AAA35586. Ref.1 | ||||||
| Sequence conflict | 1300 | 1 | R → P in AAA35585. Ref.1 | ||||||
| Sequence conflict | 1300 | 1 | R → P in AAA35586. Ref.1 | ||||||
| Sequence conflict | 1461 | 1 | Missing in CAA78744. Ref.7 | ||||||
| Sequence conflict | 1626 | 1 | S → T in AAA35585. Ref.1 | ||||||
| Sequence conflict | 1626 | 1 | S → T in AAA35586. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A gene pair from the human major histocompatibility complex encodes large proline-rich proteins with multiple repeated motifs and a single ubiquitin-like domain." Banerji J., Sands J., Strominger J.L., Spies T. Proc. Natl. Acad. Sci. U.S.A. 87:2374-2378(1990) [PubMed: 2156268] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), VARIANTS ARG-57; THR-544 AND GLU-742. Tissue: T-cell. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), VARIANT LEU-106. Tissue: Brain. |
| [3] | "Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse." Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S., Campbell R.D., Hood L. Genome Res. 13:2621-2636(2003) [PubMed: 14656967] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANTS ALA-1285; HIS-1740 AND LEU-2130. |
| [4] | "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region." Shiina S., Tamiya G., Oka A., Inoko H. Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed: 14574404] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANTS LEU-106; THR-544; LEU-1503; HIS-1740; LEU-1895 AND SER-2006. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANTS CYS-477 AND LEU-1503. Tissue: Lymph, Placenta and Uterus. |
| [7] | "Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment." Iris F.J.M., Bougueleret L., Prieur S., Caterina D., Primas G., Perrot V., Jurka J., Rodriguez-Tome P., Claverie J.-M., Dausset J., Cohen D. Nat. Genet. 3:137-145(1993) [PubMed: 8499947] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-1874 (ISOFORM 3), VARIANTS LYS-694; ALA-1415 AND ALA-1744. |
| [8] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Blocker H., Heubner D., Hoerlein A., Michel G., Wedler H., Kohrer K., Ottenwalder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 871-2157 (ISOFORM 1). Tissue: Uterine endothelium. |
| [9] | "Analysis of a high-throughput yeast two-hybrid system and its use to predict the function of intracellular proteins encoded within the human MHC class III region." Lehner B., Semple J.I., Brown S.E., Counsell D., Campbell R.D., Sanderson C.M. Genomics 83:153-167(2004) [PubMed: 14667819] [Abstract] Cited for: FUNCTION. |
| [10] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380; SER-761; THR-610 AND SER-1219, MASS SPECTROMETRY. Tissue: Epithelium. |
| [11] | "Global phosphoproteome of HT-29 human colon adenocarcinoma cells." Kim J.-E., Tannenbaum S.R., White F.M. J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1014, MASS SPECTROMETRY. |
| [12] | "Antibodies generated by a novel DNA vaccination identify the MHC class III encoded BAT2 polypeptide." Schneiders A., Thiel S., Winkler J., Moeller P., Koch N. Vaccine 23:2540-2550(2005) [PubMed: 15752841] [Abstract] Cited for: SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE. |
| [13] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-342; SER-350; SER-1089; SER-1092 AND SER-1219, MASS SPECTROMETRY. Tissue: Epithelium. |
| [14] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1347, MASS SPECTROMETRY. Tissue: Epithelium. |
| [15] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-204; SER-342; SER-350; SER-456; THR-517; SER-761 AND SER-764, MASS SPECTROMETRY. |
| [16] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1219, MASS SPECTROMETRY. Tissue: Platelet. |
| [17] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-609 AND SER-1219, MASS SPECTROMETRY. |
| [18] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-342; SER-350; SER-380; SER-383; SER-456; THR-610; SER-759; SER-761; SER-764; SER-766; THR-997; SER-1004; SER-1014; SER-1085; THR-1087; SER-1089; SER-1092; TYR-1094; SER-1147; SER-1219; SER-1306 AND THR-1347, MASS SPECTROMETRY. |
| [19] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [20] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed: 16959974] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] ILE-1087 AND HIS-1152. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| M33509 mRNA. Translation: AAA35585.1. Frameshift. M33518, M33512 Genomic DNA. Translation: AAA35586.1. Frameshift. AB210034 mRNA. Translation: BAE06116.1. Different initiation. AF129756 Genomic DNA. Translation: AAD18086.1. BA000025 Genomic DNA. Translation: BAB63391.1. AL662847 Genomic DNA. Translation: CAI17698.2. AL662801 Genomic DNA. Translation: CAI18313.1. AL805934 Genomic DNA. Translation: CAI18500.1. BX511262 Genomic DNA. Translation: CAI95572.1. CR753892 Genomic DNA. Translation: CAQ06959.1. BC030127 mRNA. Translation: AAH30127.1. BC032134 mRNA. Translation: AAH32134.1. BC042295 mRNA. Translation: AAH42295.1. BC060668 mRNA. Translation: AAH60668.1. Z15025 Genomic DNA. Translation: CAA78744.1. Frameshift. CR749245 mRNA. Translation: CAH18101.1. | |
| IPI | IPI00010700. IPI00084746. IPI00642817. IPI00885161. |
| PIR | B35098. S37671. |
| RefSeq | NP_542417.2. |
| UniGene | Hs.123239 Hs.436093 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P48634. 24 interactions. |
Proteomic databases | |
| PRIDE | P48634. |
Genome annotation databases | |
| Ensembl | ENSG00000206318. Homo sapiens. [Contig view] ENSG00000206427. Homo sapiens. [Contig view] |
| GeneID | 7916. |
| KEGG | hsa:7916. |
Organism-specific databases | |
| GeneCards | GC06P031696. GC06Pc31723. GC06Pf31721. |
| H-InvDB | HIX0032766. HIX0057983. HIX0058163. |
| HGNC | HGNC:13918. BAT2. |
| MIM | 142580. gene. |
| PharmGKB | PA25263. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | P48634. |
Family and domain databases | |
| InterPro | IPR009738. BAT2_N. [Graphical view] |
| Pfam | PF07001. BAT2_N. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 30387. |
| SOURCE | Search... |
Entry information
| Entry name | BAT2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P48634 Secondary accession number(s): B0UZE9 Q96QC6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with


